Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist
article
OA: closed
CC0
⤵ 24 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Aromatase expression in endometriosis. via openalex
- DANAZOL AND LIVER DAMAGE via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system via openalex
- Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- W2088402843 via openalex
- W2070783043 via openalex
- W2058727657 via openalex
- W2159803441 via openalex
- W2413340865 via openalex
- W6656356435 via openalex
Cited by (24)
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Hypercoagulability in women with adenomyosis who experience heavy menstrual bleeding 2023
- Low-dose letrozole – an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial 2023
- Successful management of cerebral venous sinus thrombosis due to adenomyosis: Case reports and literature review 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Danazol, Aromatase Inhibitors 2022
- Medical Treatment of Adenomyosis 2022
- Current and Prospective Treatment of Adenomyosis 2021
- Adenomyosis pathogenesis: insights from next-generation sequencing 2021
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis 2019
- Endometriosis, Infertility, and Oocyte Quality 2019
- The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility 2018
- Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia 2016
- Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis 2016
- Current and Future Medical Treatment of Adenomyosis 2016
- Adenomyosis and its impact on women fertility. 2015
- ADENOMYOSIS AND ITS IMPACT ON WOMEN FERTILITY (REVIEW ARTICLE) 2015
- Adenomyosis 2013
- The use of aromatase inhibitors in infertility and gynecology 2011
- Traitement de l’endométriose par les inhibiteurs de l’aromatase : efficacité thérapeutique et conséquences osseuses 2010
- Use of aromatase inhibitors in gynecology 2010
- Adenomyosis uteri: an update 2009
- Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists 2008
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:06.633332+00:00
License: CC0
· commercial use OK